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Abstract 
Background: The ultrafiltration rate (UFR) is one of the important factors involved in long-term 
mortality in hemodialysis (HD) patients. Presence of diabetes mellitus often affects UFR due to 
abrupt hypotension during dialysis. In this study, we aimed to find the optimal UFR to improve 
the mortality in this population with and without diabetes mellitus (DM). 
Methods: The effect of the UFR on mortality was retrospectively evaluated in 707 patients un-
dergoing regular HD from 1 June 2010 to 30 June 2017. The relationship between the UFR and 
mortality in patients in the non-DM group and those in the DM group was evaluated. Logistic 
regression analyses were used to select the determinants of mortality. Receiver operating char-
acteristic (ROC) curve analyses and survival analysis were used to determine the optimal cutoff 
points of UFR for mortality.
Results: The cutoff UFR values of the non-DM and DM groups were 12.07 ml/hr/kg and 9.66 ml/
hr/kg, respectively. A survival curve showed that in the non-DM group, the 7-year survival rate 
of patients with a UFR <12.07 ml/hr/kg was 72.6% and that in those with a UFR ≥12.07 ml/hr/kg 
was 19.6% (p<0.0001). In the DM group, the 7-year survival rate of those with a UFR <9.66 ml/
hr/kg was 66.7%, and it was 33.4% in those with a UFR ≥9.66 ml/hr/kg (p<0.0001). 
Conclusion: Lower UFR is essential for the long-term mortality of HD patients, and optimal UFR 
would be different between patients with and without DM. 
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Introduction
Excessive interdialytic weight gain (IDWG) is associated with poor outcomes 1-3); however, 
hemodialysis (HD) patients with excessive IDWG might be often forced to receive a higher ultra-
filtration rate (UFR) to reach the dry weight (DW). Previous studies have shown that an excessive 
UFR (12.37 ml/hr/kg of body weight) in patients on HD treatment is independently associated 
with an increased long-term risk of death 4). Moreover, a rapid increase in the UFR can induce 
intradialytic hypotension (IDH), which is associated with cardiovascular complications such as 
myocardial ischaemia during HD 5). IDH appears to occur more frequently in patients with diabe-
tes mellitus (DM) than in those without 6). Considering the specific dialytic complications in DM 
patients, strictly managing UFR is required to prevent poorer clinical outcomes. The evidence 
to determine the appropriate UFR based on the presence or absence of DM does not exist, and 
there are few reports about the most suitable UFR cutoff value for DM patients. In this study, we 




Informed consent was obtained from all individual participants included in the study. All 
procedures performed in studies involving human participants were in accordance with the ethi-
cal standards of the institutional and national research committee at which the studies were 
conducted (IRB approval number NCT03471299) and with the 1964 Helsinki Declaration and its 
later amendments or comparable ethical standards. 
Patients and study measurements
We enrolled 759 patients who had undergone maintenance HD for > 1 year at the hemodi-
alysis hospital, Japan. We examined data from all individuals who underwent maintenance HD 
treatment three times weekly from 1 June 2010 to 30 June 2017. Four hundred thirty patients 
(57%) were men, 255 (34%) had DM, and 222 (29%) had cardiovascular disease (CVD). Patients 
were excluded if they had peritoneal dialysis combined with HD, did not have records of labora-
tory investigations during this period, or were transferred to another hospital or lost to follow-up. 
We collected data regarding the demographic characteristics, DM history, CVD history, labo-
ratory results, and the number and causes of death during the entire study period. The demo-
graphic characteristics included age (years), sex, dialysis history (years), primary kidney disease, 
height (cm), DW (kg), body mass index ([BMI], kg/m2), HD dose (Kt/Vure), IDWG (%), removal 
of body water ([RBW], %), % creatinine generation rate (%CGR), geriatric nutritional risk index 
(GNRI), and UFR (ml/hr/kg) at baseline (1 June 2010). CVD included the presence of ischaemic 
heart disease, peripheral vascular disease, and cerebral vascular disease. The DW was deter-
mined clinically and reflected the lowest weight the patient could tolerate without intradialytic 
symptoms and hypotension and without overt fluid overload. The DW was continuously updated 
according to the medical doctors’ changes in orders throughout the observation period. 
The BMI was calculated as the patient’s DW divided by the square of the patient’s height. 
The IDWG was calculated as the patients’ weight before the HD session (beginning of the week) 
minus the weight after the previous HD session (end of the week), divided by the DW. The RBW 
was calculated as the patient’s weight before the HD session minus that afterwards, divided by 
the DW. The UFR was obtained by subtracting the patient’s weight after the HD session from that 
before, divided by the DW and then by the HD time. The UFR was adapted to reach the DW dur-
ing the preset dialysis time in a basic direction. The IDWG, RBW, and UFR were determined us-
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ing the median values of four different measurements at the beginning of one week in a month-
long period and were calculated as the median values of all measurements during this period. 
The HD dose was calculated at the beginning of the week at the start of the study and every 6 
months until its end. The Kt/Vure, %CGR, and GNRI were determined according to single-pool 
urea kinetics models 7). The GNRI was calculated at baseline as: GNRI = (14.89 × serum albumin 
concentration [g/dL] + (41.7 × [body weight/ideal body weight]) 8). The ideal body weight was 
calculated from the height and a BMI of 22 9). 
Blood samples (5 ml) were obtained immediately before the HD session began for pre-HD 
measurements and at the end of the HD session for post-HD measurements on the first day of the 
week. Pre-HD serum concentrations of blood urea nitrogen, albumin, calcium, and phosphorus 
were measured monthly, at the beginning of every week. Post-HD concentrations of blood urea 
nitrogen were measured once every 6 months (June and December). The blood flow rates ranged 
from 200-350 ml/min, the dialysate flow rate ranged from 500-700 ml/min, and the dialysate 
temperature ranged from 35-37°C. 
The patient’s blood pressure was measured before (pre-systolic and diastolic blood pressure) 
and after (post-systolic and diastolic blood pressure) each HD session with an automatic sphyg-
momanometer. A cuff band was wrapped around the upper arm, contralateral to the location of 
vascular access. All study data were obtained via a medical chart review. Since 52 patients were 
lost to follow-up because they were transferred from our hospital, the final sample size was 707 
patients. The median (interquartile range [IQR]) of the patients’ ages and dialysis durations were 
67.8 (75.4-59.9) and 8.9 (14.9-4.5) years, respectively. 
Statistical analysis
All data are expressed as a median with IQR. Patients were classified according to whether 
DM was present or absent. The presence or absence of DM was determined by patients whose 
primary disease for introducing HD was diabetic nephropathy and who are currently receiving 
treatment for DM. Differences between groups were assessed with Fisher’s exact probability test 
and Mann-Whitney’s U test. We performed a univariate logistic regression analysis to select the 
determinants of mortality. In the univariate logistic regression analysis, the presence or absence 
of death was the dependent variable. All-cause death was the endpoint. Age, sex, dialysis history, 
presence of DM, presence of CVD, IDWG, RBW, %CGR, UFR, GNRI, serum albumin concentra-
tion, and Kt/Vure were included in the models as univariate variables. In addition, we performed 
a multiple logistic regression analysis to estimate the adjusted association between these vari-
ables and mortality and establish the odds that variables would be associated with death. Risk 
factors with a significant association with death in the univariate logistic regression analysis were 
included in the model. However, if these factors did not have statistical significance in the uni-
variate logistic regression analysis, the influential risk factors were retained in the models based 
on clinical precedent and evidence of plausibility, as the risk factors for mortality in patients un-
dergoing HD 10). We selected age and the GNRI as covariates to adjust the UFR to avoid multicol-
linearity in the statistical analysis. IDWG and RBW were discarded to avoid biased estimations, 
since collinear parameters contain highly redundant information. Survival curves were obtained 
using the Kaplan-Meier estimation method and compared using a log-rank test to determine the 
difference in survival rates between DM patients who died and those who survived. The survival 
time for each patient was determined by the number of days from the start of this study to the 
end of the observation period or the date of the patient’s death. The sensitivity and specificity 
of the groups of non-DM and DM patients were calculated for each UFR cutoff value to generate 
receiver operating characteristic (ROC) curves, including the areas under the curve (AUC) and 
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their 95% confidence intervals (CI). P-values <0.05 indicated statistical significance. All statistical 
analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, 




Table 1 shows the demographic characteristics of 707 patients. The patients’ ages and di-
alysis durations at baseline are expressed as median values (IQR). DW, BMI, HD time, serum 
albumin concentration, pre-systolic and diastolic blood pressure, post-systolic and diastolic blood 
pressure, UFR, IDWG, BRW, GNRI, %CGR, and Kt/Vure during the study period are expressed as 
the median values (IQR) of all measurements. Among these patients, 399 (56%) were men, 236 
(33%) had DM, and 215 (30%) had CVD. During the 7-year follow-up period, 196 patients (42%) 
in the non-DM group and 118 (50%) in the DM group died. In the non-DM group, the HD time, 
serum albumin concentration, pre-diastolic blood pressure, GNRI, %CGR, and Kt/Vure were sig-
nificantly higher in patients who survived than in patients who died (all, p<0.05). However, in pa-
tients in the non-DM group who died, age, UFR, IDWG, and RBW were significantly higher than 
in patients who survived (all, p<0.001). In the DM group, DW, HD time, serum albumin concen-
tration, GNRI, and %CGR were significantly higher in patients who survived than in those who 
died (all, p<0.001). However, in patients in the DM group who died, age, pre-systolic and pre-
diastolic pressure, UFR, IDWG, and RBW were significantly higher than in patients who survived 
(all, p<0.001). In the non-DM and DM groups, no differences were observed between patients 
who survived and those who died regarding sex, BMI, post-systolic and post-diastolic pressure, 






survived died survived died
Number of patients 707 275 196 − 118 118 −
Age, yr 67.8 (75.4–59.9) 62.2 (69.3–55.1) 74.1 (83.5−66.1) <0.0001 ** 63.5 (69.5–56.5) 74.2 (79.1–68.8) <0.0001 **
Sex (men/women) 399 / 308 146 / 129 112 / 84 0.399 76 / 42 65 / 53 0.184
Dialysis vintage, yr 8.9 (14.9–4.5) 10.3 (17.7–5.9) 11.2 (20.2−4.7) 0.547 5.8 (9.6–2.8) 6.6 (10.3–3.6) 0.088
Duration of survival period, day − − 1305.6 (1871.52−567.5) − − 1244.5 (1757.3−591.5) −
Dry weight, kg 53.0 (61.0–45.5) 54.0 (61.3–47.0) 50.0 (56.5–42.9) <0.0001 ** 59.8 (69.4–52.0) 49.3 (59.4–43.0) <0.0001 **
Body mass index, kg/m2 21.0 (23.4–18.9) 21.2 (23.5–19.3) 20.3 (22.1–18.5) 0.050 22.8 (25.9–20.8) 20.6 (22.9–17.9) 0.757
Heamodialysis time, hr 4.0 (5.0−4.0) 4.0 (5.0−4.0) 4.0 (4.0−4.0) <0.0001 ** 4.0 (5.0−4.0) 4.0 (4.0−4.0) <0.001 **
Serum albumin concentration, g/dL 3.7 (4.0–3.5) 3.9 (4.1–3.7) 3.6 (3.8–33) <0.0001 ** 3.8 (4.0–3.6) 3.6 (3.8–3.2) <0.0001
pre systolic blood pressure, mmHg 142 (155−129) 141 (153−128) 144 (156−131) 0.153 136 (148−121) 149 (161−134) <0.0001 **
pre diastolic blood pressure, mmHg 76 (84−66) 80 (88−70) 75 (82−67) <0.001 ** 70 (79−59) 74 (82−63) <0.0001 **
post systolic blood pressure, mmHg 128 (1410−1142) 128 (140−114) 129 (142−116) 0.305 120 (136−103) 130 (152−116) 0.065
post diastolic blood pressure, mmHg 67 (76−60) 70 (78−60) 68 (76−60) 0.164 64 (71−52) 64 (74−56) 0.233
History of cardiovascular disease 215 88 67 0.619 31 29 0.881
Ultrafiltration rate, ml/hr/kg 9.7 (12.4−7.4) 8.5 (10.7−6.6) 12.2 (15.3−9.4) <0.0001 ** 8.7 (10.7−7.9) 11.5 (13.5−8.5) <0.0001 **
Interdialytic weight gain, % 4.2 (5.3−3.2) 3.9 (5.1−2.9) 4.4 (5.24−3.5) <0.001 ** 4.0 (5.0−3.2) 4.6 (5.9−3.7) 0.002 **
Removal of body water, % 3.8 (4.5−3.1) 3.6 (4.4−2.9) 4.0 (4.36−3.3) 0.006 * 3.6 (4.3−3.1) 4.0 (4.7−3.3) 0.009 **
Geriatric nutritional risk index 95.3 (99.1–90.3) 96.8 (99.8–93.7) 92.3 (96.8–86.2) <0.0001 ** 98.3 (100.8–93.8) 93.3 (96.8–84.7) <0.0001 **
%Creatinine generation rate 112.4 (128.4–93.6) 122.3 (136.9–111.4) 104.3 (120.9–82.1) <0.0001 ** 110.2 (122.8–94.3) 101.1 (118.3–75.7) 0.006 **
Kt/Vurea 1.83 (2.04–1.62) 1.91 (2.12–1.64) 1.83 (2.04–1.62) 0.033 * 1.81 (2.00–1.60) 1.74 (1.93–1.62) 0.135
Table 1. Characteristics of patients with DM and those without DM in terms of 7-year mortality
All values are expressed as the median (interquartile range).  
DM: diabetes mellitus 
Fisher’s exact probability tests and Mann-Whitney’s U tests were used in the analysis.  
a indicates patients who survived vs. those who died in the non-DM group.  
b indicates patients who survived vs. those who died in the DM group. 
* there was a significant difference between patients who survived and those who died. ** p<0.01, * p<0.05.
Table1. Character stics of patient ith  and thos  without DM in terms of 7-years mortality
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Univariate and multiple logistic regression analyses
Table 2 shows the results of the univariate logistic regression analysis. In all patients, age, 
the presence of DM, RBW, IDWG, and UFR were associated with a significant increase in mortal-
ity (all, p<0.0001). The serum albumin concentration, BMI, %CGR, GNRI, and HD time were as-
sociated with a significant reduction in mortality (all, p<0.0001). In the non-DM group, age, RBW, 
IDWG, and UFR were associated with a significant increase in mortality (p<0.0001). The serum 
albumin concentration, BMI, Kt/Vure, %CGR, GNRI, and HD time were associated with a signifi-
cant reduction in mortality (all, p<0.05). In the DM group, age, RBW, IDWG, and UFR were asso-
ciated with a significant increase in mortality (all, p<0.0001). The serum albumin concentration, 
BMI, Kt/Vure, %CGR, GNRI, and HD time were associated with a significant reduction in mortal-
ity (all, p<0.001). 
Table 3 shows the results of the multiple logistic regression analysis. In the model, we in-
cluded age, sex, dialysis duration, presence of CVD, IDWG, RBW, UFR, %CGR, GNRI, and serum 
albumin concentration. There was no statistically significant difference in patients with and those 
without CVD, but this factor was included and retained in the model based on clinical precedent 
and evidence from previous studies. After selection with the multiple logistic regression analysis, 
the factors with statistical significance for death were age, GNRI, IDWG, RBW, and UFR.
Overall Non–DM group DM group
OR (95% CI) p–values OR (95% CI) p–values OR (95% CI) p–values
Age, yr 1.10 (1.08–1.12) <0.0001 ** 1.10 (1.07–1.12) <0.0001 ** 1.11 (1.08–1.15) <0.0001 **
Sex 1.00 (0.75–1.36) 0.975 0.85 (0.59–1.23) 0.384 1.48 (0.88–2.49) 0.145
Dialysis vintage, yr 1.01 (0.10–1.03) 0.166 1.02 (0.99–1.04) 0.071 1.05 (0.99–1.12) 0.098
History of diabetes mellitus 1.40 (1.02–1.92) 0.035 – – – –
History of cardiovascular disease 1.04 (0.76–1.44 ) 0.804 1.22 (0.81–1.83) 0.334 0.74 (0.43–1.27) 0.275
Body mass index, kg/m2 0.89 (0.85–0.93) <0.0001 **  0.91 (0.86–0.96) <0.01 ** 0.84 (0.78–0.91) <0.0001 **
Heamodialysis time, hr 0.37 (0.27–0.52) <0.0001 **  0.44 (0.30–0.64) <0.001 ** 0.27 (0.14–0.52) <0.001 **
Kt/Vurea 0.66 (0.41–1.06) 0.084 0.49 (0.28–0.86) <0.05 * 2.06 (0.79–5.38) 0.141
Removal of body water, % 1.83 (1.61–2.09) <0.0001 ** 2.19 (1.83–2.60) <0.0001 ** 1.42 (1.17–1.72) <0.001 **
Serum albumin concentration, g/dL 0.12 (0.08-0.19) <0.0001 ** 0.01 (0.05–0.17) <0.0001 ** 0.20 (0.10–0.40) <0.0001 **
Interdialytic weight gain, % 1.34 (1.23–1.46) <0.0001 ** 1.55 (1.38–1.75) <0.0001 ** 1.06 (0.93–1.21) 0.368
Geriatric nutritional risk index  0.91 (0.88–0.93) <0.0001 ** 0.90 (0.87–0.92) <0.0001 ** 0.92 (0.89–0.95) <0.0001 **
%Creatinine generation rate 0.97 (0.97–0.98) <0.0001 ** 0.97 (0.96–0.97) <0.0001 ** 0.99 (0.98–0.10) <0.01 **
Ultrafiltration rate, ml/hr/kg 1.37 (1.29–1.45) <0.0001 ** 1.45 (1.35–1.57) <0.0001 ** 1.25 (1.14–1.36) <0.0001 **
Tabel 2. The univariate association between individual covariates and 7-year mortality in the non-DM and DM groups in the 
logistic regression model
CI: confidence interval; DM: diabetes mellitus 
Odds ratios and CIs were calculated using a univariate logistic regression analysis. ** p<0.01. 
* there was a significant difference. ** p<0.01, * p<0.05. 
Odds ratio 95% CI p–values
Age, yr 1.08 1.06–1.10 <0.0001 **
Geriatric nutritional risk index 0.94 0.92–0.96 <0.0001 **
Interdialytic weight gain, % 1.23 1.06–1.43     <0.01 **
Removal body water, % 0.51 0.34-0.77     <0.01 **
Ultrafiltration rate, ml/hr/kg 1.22 1.06–1.41     <0.01 **
Table 3. Odds ratios in the multiple logistic regression analysis for predicting 7-
year mortality
CI: confidence interval 
Odds ratios and CIs were calculated using a multiple logistic regression analysis. The 
model was adjusted for age, sex, dialysis history, presence of cardiovascular disease, 
interdialytic weight gain, removal of body water , ultrafiltration rate, % creatinine 
generation rate, geriatric nutritional risk index, and serum albumin concentration.  
* there was a significant difference. ** p<0.01.
Table2. The univariate association between individual covariates and 7-years mortality in the non-DM and 
DM groupe  i  th logistic regression model
l 3. s ratios in the multiple logistic regression analysis for predicting 
7-years mor ality
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UFR cutof  values for mortality
Figure 1 shows the relative ROC curves for UFR in the non-DM and DM groups, as well as the 
AUC and its CIs. The discrimination potential of UFR was estimated to be evaluated at baseline, 
in predicting death at 7 years. The ROC curve and cutoff that minimized the absolute difference 
between the sensitivity and specificity were calculated for the UFR. In the non-DM group, the 
UFR cutoff for mortality was 12.07 ml/hr/kg, with 52% sensitivity and 91% specificity. In the DM 
group, the UFR cutoff for mortality was 9.66 ml/hr/kg, with 67% sensitivity and 66% specific-
ity. The AUCs to predict the appropriate UFR in the non-DM and DM groups were 0.78 (95% CI: 





























UFR cutoff threshold = 12.07 ml/hr/kg
AUC (95% CI) = 0.78 (0.74–0.83)
Fig. 1. ROC curve for UFRs and mortality
UFR cutoff threshold = 9.66 ml/hr/kg
AUC (95% CI) = 0.70 (0.63–0.76)
(a) Non–DM group (n=471) (b) DM group (n=236)
UFRs were adjusted for age and the geriatric nutritional risk index.
ROC: receiver operating characteristic; DM: diabetes mellitus; UFR: ultrafiltration rate; AUC: area under 
the curve 
Survival analysis 
Figure 2 shows the survival curves in the multiple logistic analysis for significant predictors in 
the non-DM and DM groups. Data were adjusted for age and GNRI. Age and GNRI were selected 
as covariates to adjust the UFR, in order to avoid multicollinearity in the statistical analyses. 
With a follow-up of 7 years, the volume of the UFR in each group were defined according to the 
ROC-derived UFR threshold of 12.07 ml/hr/kg (median 7.1 years versus 4.8 years, p<0.0001) and 
9.66 ml/hr/kg (median 7.1 years versus 4.5 years, p<0.0001), respectively. The 470 patients (67%) 
in the non-DM group were divided into two sub-groups: UFR >12.07 ml/hr/kg (127 patients [27%]) 
and UFR ≤12.07 ml/hr/kg (344 patents [73%]). Similarly, the 236 patients (33%) in the DM group 
were divided into two sub-groups: UFR >9.66 ml/hr/kg (68 patients [29%]) and UFR ≤9.66 ml/hr/
kg (168 patients [71%]). During the follow-up period, in the non-DM group, 102 patients (80%) 
with a UFR >12.07 and 94 (27%) with a UFR ≤12.07 ml/hr/kg died, and the median survival pe-
riods were 4.9 (6.4-2.4) and 7.1 (7.1-6.0) years, respectively. In the DM group, 50 patients (74%) 
with a UFR >9.66 and 68 (40%) with a UFR ≤9.66 ml/hr/kg died, and the median survival periods 
were 4.9 (6.4-2.4) and 7.1 (7.1-6.0) years, respectively. 
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Discussion
We assessed the association between the UFR and long-term mortality in HD patients. UFRs 
over 12.07 and 9.66 ml/hr/kg were independently associated with increased odds of death in 
non-DM and DM patients, respectively. This is the first study to report the cutoff UFR values that 
are associated with mortality in a 7-year period, comparing non-DM and DM patients in the same 
HD environment. 
Many investigations have reported that higher weight gain and overload were associated with 
increased mortality, and an excessively high UFR was strongly associated with mortality in HD 
patients. A previous 5-year prospective observational multicenter study observed better survival 
in patients with a UFR <12.37 ml/hr/kg body weight and recommended longer or more frequent 
dialysis sessions for these patients 4). Another study in the US on 110,880 HD patients reported 
that a UFR ≥10 mL/hr/kg of body weight conferred the highest risk and was independently as-
sociated with higher all-cause and cardiovascular mortality in patients with incident HD 12). Be-
cause a UFR of 15 ml/hr/kg is equal to the removal of 6% of body weight in water in 4 hours, the 
average UFR would be ≤15 ml/hr/kg, and >6% weight loss between two consecutive HD sessions 
was associated with a significant increase in the risk of death 13). Recently, we reported that in 
patients with a UFR >15 ml/hr/kg, imbalance of the autonomic nervous activity occurred even 
without blood pressure variations during an HD session 14). UFR has serious implications for mor-
bidity and mortality, but the adequate management of UFR is a critical issue. There is no doubt 
that excessive UFRs are strongly related to adverse outcomes and mortality, and in many cases, 
a suitable UFR is a critical and challenging aspect of HD.
The major cause of HD-associated hypotension is a reduced circulating plasma volume due 
to a delay in the plasma refilling rate that is caused by excess water removal 15). As the plasma 
volume decreases, the baroreceptor reflex acts as a compensatory mechanism, stimulating the 
sympathetic nervous system, enhancing cardiac contraction, and increasing heart rate and blood 
pressure. A decreased circulating plasma volume could result in myocardial ischaemia that is as-
sociated with cardiovascular risk and mortality 16). Additionally, changes in autonomic nervous 
































12.07< UFR (ml/hr/kg) 9.66< UFR (ml/hr/kg)






Follow–up (years) Follow–up (years)
(a) Non–DM group (n=471) (b) DM group (n=236)
Fig. 2.  Kaplan-Meier curves for the log-rank analysis, using the UFR as a categorical variable that was 
defined according to the ROC curve-derived ultrafiltration rate threshold of 12.07 ml/hr/kg in non-DM 
patients (a) and 9.66 ml/hr/kg in DM patients (b). 
UFR: ultrafiltration rate; ROC: receiver operating characteristic; DM: diabetes mellitus
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activity and heart rate precede the appearance of transient myocardial ischaemia 17). Moreover, 
autonomic nervous dysfunction, arteriosclerosis, and cardiac dysfunction are also cause of IDH. 
In this study, the cutoff UFR value in the DM group was less than that in the non-DM group. 
Thus, removing water rapidly from DM patients undergoing HD could be particularly hazardous 
clinically, as the removal of water would be linked to hemodynamic failure that is peculiar to pa-
tients with DM undergoing HD. This could result in a vicious cycle of decreased blood pressure.
Another finding was that the HD time and nutrition status possibly had a direct impact upon 
the survival of HD patients. Patients who died were significantly older, had a shorter HD time, 
and had lower Kt/Vure, GNRI, and %CGR values than did patients who survived (Table 1). Kt/
Vure did not have an independent influence on patient survival in the multiple logistic regression 
analysis of the non-DM group, but it did have an impact in the DM group. Although these results 
do not negate the fact that a higher Kt/Vure reduces mortality, it indicates that higher Kt/Vure is 
due to a longer HD time. Increasing the HD time could enhance the beneficial effect of decreas-
ing the UFR values and mortality. 
Furthermore, the serum albumin concentration, GNRI, and %CGR were significantly lower 
in patients who died than in patients who survived, and these had an independent influence on 
patient survival in the multiple logistic regression analysis. Lower GNRI values suggested that 
patients who died had poorer nutritional status than did those who survived and that the GNRI 
value directly influenced survival, but BMI did not (Table 3). The GNRI is a synthetic variable of 
the serum albumin concentration and weight, and is strongly influenced by the serum albumin 
concentration. Furthermore, the GNRI reflects the influence of emaciation more strongly than 
that of obesity, because weight is set as equal to 1 of the upper limit of the weight if 1≤ the actual 
measured body weight/ideal weight. These results lead to a dignified for serum albumin concen-
tration than for patients’ weight, and agreed with that GNRI may have a better prognostic factor 
than serum albumin concentration or BMI alone 18).
Limitations
First, although we considered confounding variables that were possibly associated with both 
the UFR and mortality, other residual factors, especially CVD, are associated with UFR and dia-
lytic hemodynamics such as IDH. In the present study, it was possible that dialytic hemodynam-
ics such as IDH could have been responsible for variations in the UFR. Additionally, we did not 
consider lifestyle habits that might have been associated with weight gain such as the patients’ 
physical activities, diet, smoking status, or alcohol intake. We also could not exclude variables 
such as antihypertensive or antihypotensive drug use and complications to minimize the risk of 
residual confounders. Second, this study was a retrospective, single-center nature. A well-de-
signed, prospective study with a propensity score analysis will be needed to confirm our findings. 
Third, in the DM group, the AUC, sensitivity, specificity, and cutoff values were low. A higher 
sensitivity may be required in primary diagnostic settings. It may be more difficult to predict the 
prognosis of patients with DM when determining the survival risk using the UFR because of the 
complexity of the pathology of diabetes. Finally, observational UFR may have been introduced as 
misclassification bias. That is, diet and drinking volume during HD may be added to the amount 
of water removal in an HD session and may be different from the amount of water removal 
against real weight gain. With misclassification, the UFR might have been overestimated. 
Conclusion
We show that high UFRs are associated with an increased mortality risk in patients undergo-
ing HD. Better survival was observed with UFR ≤12.07 ml/h/kg and UFR ≤9.66 ml/h/kg in HD 
Yoshihiro Tsuji: The association between ultrafiltration rate and mortality in a cohort of chronic 
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patients with non-DM and DM, respectively. Lower UFR might be essential for improving the 
long-term mortality of HD patients. 
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